This inventor holds 2 USPTO granted patents. Top assignees: Institut Pasteur, National Institute of Health and Medical Research. Active years: 2006-2008.
Company Filing History:
2 out of 897 
1 out of 1,853 
Years Active: 2006-2008
Title: The Innovative Contributions of Stephen Girardin
Introduction
Stephen Girardin is a notable inventor based in Vincennes, France. He has made significant contributions to the field of biomedical research, particularly in the modulation of Nod1 activity. With a total of 2 patents to his name, Girardin's work has implications for therapeutic applications in inflammation and apoptosis.
Latest Patents
Girardin's latest patents include a method for modulating Nod1 activity, which involves providing cells that express a functional Nod1 and bringing these cells into contact with a molecule related to MTP. This method aims to modulate inflammation and/or apoptosis, showcasing his innovative approach to addressing complex biological processes.
Career Highlights
Throughout his career, Stephen Girardin has worked with prestigious institutions such as Institut Pasteur and the Institut National de la Santé et de la Recherche Médicale. His research has focused on understanding the mechanisms of immune response and developing therapeutic strategies to enhance health outcomes.
Collaborations
Girardin has collaborated with esteemed colleagues, including Philippe J. Sansonetti and Dana Philpott. These partnerships have enriched his research and contributed to advancements in the field of immunology.
Conclusion
Stephen Girardin's innovative work in modulating Nod1 activity highlights his significant contributions to biomedical research. His patents and collaborations reflect a commitment to advancing our understanding of immune responses and developing therapeutic applications.